An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A small set of studies and articles is making a claim that a peptide called GHK‑Cu can help with erectile dysfunction (ED). The headlines make it sound like a new, simple fix. But the actual evidence behind those headlines is limited and not the same as the big, well-controlled drug trials people usually expect. GHK‑Cu is a tiny molecule that naturally occurs in the body and can also be made in a lab. It’s often called a peptide (which just means a short chain of amino acids) bound to a copper ion. Researchers have studied it mostly because it seems to help with wound healing, skin repair, and reducing inflammation in lab experiments. It isn’t a hormone like testosterone, and it’s not a pill or injection that’s been approved by regulators specifically for treating ED. What the research shows so far is mostly early-stage and indirect. A handful of lab studies and a few small animal experiments suggest GHK‑Cu can affect blood vessels, inflammation, or tissue repair — all things that matter for erections. But I couldn’t find large human clinical trials that test GHK‑Cu for ED in a reliable way. That means the existing data might show biological effects in cells or improvements in animals, or a few reported cases, but not the kind of proof you’d get from randomized trials in people that measure sexual function and compare to a placebo. Why this matters is straightforward: ED can have physical and emotional causes, and treatments that help blood flow or tissue health could theoretically help some people. If GHK‑Cu really improved blood vessel function or tissue repair in the penis, it might one day be useful either alone or alongside existing treatments. Right now, though, it’s mostly a research idea rather than a ready-made therapy. People curious about new options should be cautious and talk to a healthcare provider about proven choices first. There are important caveats and risks. Because GHK‑Cu hasn’t gone through large human trials for ED, we don’t have good data on effective doses, long-term safety, or side effects when used for this purpose. Products sold online may vary in quality and purity. People with cardiovascular disease, those taking blood-pressure or blood-thinning medications, and anyone with hormone-sensitive conditions should be especially careful and consult their doctor. Regulatory agencies haven’t approved GHK‑Cu as an ED treatment, so claims on commercial sites may be premature. Bottom line: GHK‑Cu is an interesting molecule with some lab and animal data that hint at benefits for tissues and blood vessels, but solid evidence that it treats erectile dysfunction in people is not yet available.
Source: nk-osijek.hr